Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity.
Czerkinsky
C
C
Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.
Sun
J B
JB
Lebens
M
M
Li
B L
BL
Rask
C
C
Lindblad
M
M
Holmgren
J
J
D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology / Q000517:prevention & control; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002772:Cholera Toxin; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control; D004337:Drug Carriers; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000517:prevention & control; D007108:Immune Tolerance; D007328:Insulin / Q000008:administration & dosage; D007413:Intestinal Mucosa / Q000276:immunology*; D051379:Mice; D016688:Mice, Inbred NOD; D014612:Vaccines / Q000008:administration & dosage*
D000941:Antigens; D001428:Bacterial Vaccines; D004337:Drug Carriers; D007328:Insulin; D014612:Vaccines; D002772:Cholera Toxin